Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004;2000(1):CD001987.
doi: 10.1002/14651858.CD001987.pub2.

Laser prostatectomy for benign prostatic obstruction

Affiliations

Laser prostatectomy for benign prostatic obstruction

R M Hoffman et al. Cochrane Database Syst Rev. 2004.

Abstract

Background: Symptomatic benign prostatic obstruction is a common problem for older men. The gold standard treatment, transurethral resection of the prostate (TURP), significantly improves urinary symptoms and urinary flow. However, TURP has up to a 20% morbidity. Currently, there are a number of minimally invasive procedures that may be safe, effective alternatives to TURP. One promising surgical technique is laser prostatectomy.

Objectives: To assess the therapeutic efficacy and safety of laser prostatectomy techniques for treating men with symptomatic benign prostatic obstruction.

Search strategy: Randomized controlled trials were identified from the Cochrane Collaboration Library, MEDLINE, EMBASE, bibliographies of retrieved articles and reviews, and contacting expert relevant trialists and laser manufacturers.

Selection criteria: All randomized controlled trials evaluating laser prostatectomy treatment for men with symptomatic BPH. Trials were eligible if they (1) were randomized comparisons of a laser technique with TURP, (2) included at least 10 men with BPO in each treatment arm, (3) provided at least 6-months follow-up, and (4) included clinical outcomes such as urologic symptom scales or urodynamic measurements.

Data collection and analysis: Data extraction and assessment of methodologic quality was performed independently by two reviewers. Information on study design, subject and treatment characteristics, adverse events, urinary symptoms, and urinary flow were extracted using a standard form.

Main results: 20 studies involving 1898 subjects were evaluated, including studies 4 with multiple comparisons. We found 8 comparisons of TURP with contact lasers, 8 with non-contact lasers, 4 with hybrid techniques, and one with interstitial laser coagulation (ILC). Two studies compared transurethral electrovaporization (TUVP) with contact lasers, one study compared interstitial laser coagulation with transurethral microwave thermotherapy (TUMT), and one study compared holmium contact lasers (HoLRP) with open prostatectomy. Among the studies comparing laser prostatectomy with TURP, follow-up duration ranged from 6 to 36 months. Mean age (67.2 yrs), mean baseline symptom score (20.2), and mean baseline peak urinary flow (9.2 ml/s) did not differ by treatment group. The pooled percentage improvements for mean urinary symptoms ranged from 59% to 68% with lasers and 63% to 77% with TURP. The improvements for mean peak urinary flow ranged from 56% to 119% with lasers and 96% to 127% with TURP. Overall, laser subjects were less likely to receive transfusions or develop strictures and their hospitalizations were shorter. Non-contact laser subjects were more likely to have dysuria, urinary tract infection, and retention. Re-operation occurred more often following laser procedures.

Reviewer's conclusions: Laser techniques are a useful alternative to TURP for treating BPO. Small sample sizes and differences in study design limit any definitive conclusions regarding the preferred type of laser technique. Data were insufficient to compare laser techniques with other minimally invasive procedures.

PubMed Disclaimer

Conflict of interest statement

None

Update of

  • doi: 10.1002/14651858.CD001987

Similar articles

Cited by

References

References to studies included in this review

Anson 1995 {published data only}
    1. Anson K, Nawrocki J, Buckley J, Fowler C, Kirby R, Lawrence W, Paterson P, Watson, G. A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology 1995;46(3):305‐10. [MEDLINE: ] - PubMed
    1. Buckley JF, Ligam V, Paterson P and the British ELAP Group. [Endoscopic laser ablation of the prostate gland (ELAP)]. J Urol 1994;151:Abstract 5.
Carter 1999a {published data only}
    1. Carter A, Sells H, Speakman M, Ewings P, MacDonagh R, O'Boyle P. A prospective randomized controlled trial of hybrid laser treatment or transurethral resection of the prostate, with a 1‐year follow‐up. BJU Int 1999;83(3):254‐9. [MEDLINE: ] - PubMed
Costello 1995 {published data only}
    1. Costello AJ, Crowe HR, Jackson T, Street A. A randomised single institution study comparing laser prostatectomy and transurethral resection of the prostate. Ann Acad Med Sing 1995;24(5):700‐4. [MEDLINE: ] - PubMed
Cowles 1995 {published data only}
    1. Cowles RS 3rd, Kabalin JN, Childs S, Lepor H, Dixon C, Stein B, Zabbo A. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology 1995;46(2):155‐60. [MEDLINE: ] - PubMed
Donovan 2000 {published data only}
    1. Donovan JL, Peters TJ, Neal DE, Brookes ST, Gujral S, Chacko KN, Wright M, Kennedy LG, Abrams P. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study. J Urol 2000;164(1):65‐70. [MEDLINE: ] - PubMed
Gilling 1998a {published data only}
    1. Gilling PJ. Cass CB. Malcolm A. Cresswell M. Fraundorfer MR. Kabalin JN. Holmium laser resection of the prostate versus neodymium:yttrium‐aluminum‐garnet visual laser ablation of the prostate: a randomized prospective comparison of two techniques for laser prostatectomy. Urology 1998;51(4):573‐7. [MEDLINE: ] - PubMed
Gilling 1999 {published data only}
    1. Gilling PJ, Mackey M, Cresswell M, Kennett K, Kabalin JN, Fraundorfer MR. Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1‐year followup. J Urol 1999;162(5):1640‐4. [MEDLINE: ] - PubMed
Gujral 2000 {published data only}
    1. Gujral S, Abrams P, Donovan JL, Neal DE, Brookes ST, Chacko KN, Wright MJP, Timoney AG, Peters TJ. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention. J Urol 2000;164:59‐64. - PubMed
Kabalin 1995 {published data only}
    1. Kabalin JN. Laser prostatectomy performed with a right angle firing neodymium:YAG laser fiber at 40 watts power setting. J Urol 1993;150(1):95‐9. - PubMed
    1. Kabalin JN, Gill HS, Bite G, Wolfe V. Comparative study of laser versus electrocautery prostatic resection: 18‐month followup with complex urodynamic assessment. J Urol 1995;153(1):94‐8. [MEDLINE: ] - PubMed
Keoghane 2000a {published data only}
    1. Keoghane SR, Cranston DW, Lawrence KC, Doll HA, Fellows GJ, Smith JC. The Oxford Laser Prostate Trial: a double‐blind randomized controlled trial of contact vaporization of the prostate against transurethral resection; preliminary results. Br J Urol 1996;77(3):382‐5. [MEDLINE: ] - PubMed
    1. Keoghane SR, Lawrence KC, Jenkinson CP, Doll HA, Chappel DB, Cranston DW. The Oxford Laser Prostate Trial: sensitivity to change of three measures of outcome. Urology 1996;47(1):43‐7. [MEDLINE: ] - PubMed
    1. Keoghane SR. Doll HA. Lawrence KC. Jenkinson CP. Cranston DW. The Oxford Laser Prostate Trial: sexual function data from a randomized controlled clinical trial of contact laser prostatectomy. Eur Urol 1996;30(4):424‐8. [MEDLINE: ] - PubMed
Kuntz 2002 {published data only}
    1. Kuntz RM, Lehrich K. Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm: a randomized prospective trial of 120 patients. J Urol 2002;168(4 Pt 1):1465‐9. - PubMed
Mottet 1999 {published data only}
    1. Mottet N, Anidjar M, Bourdon O, Louis JF, Teillac P, Costa P, Duc A. Randomized comparison of transurethral electroresection and holmium: YAG laser vaporization for symptomatic benign prostatic hyperplasia. J Endourol 1999;13(2):127‐30. [MEDLINE: ] - PubMed
Norby 2002 {published data only}
    1. Norby B, Nielsen HV, Frimodt‐Moller PC. Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia. BJU Int 2002;90(9):853‐62. - PubMed
Sengor 1996 {published data only}
    1. Sengor F, Kose O, Yucebas E, Beysel M, Erdogan K, Narter F. A comparative study of laser ablation and transurethral electroresection for benign prostatic hyperplasia: results of a 6‐month follow‐up. Br J Urol 1996;78(3):398‐400. [MEDLINE: ] - PubMed
Shingleton 1998 {published data only}
    1. Shingleton WB, Renfroe LD, Kolski JM, Fowler JE, Jr. A randomized prospective study of transurethral electrovaporization vs laser ablation of the prostate in men with benign prostatic hypertrophy. Scand J Urol Nephrol 1998;32:266‐9. - PubMed
Shingleton 1999 {published data only}
    1. Shingleton WB, Terrell F, Renfroe DL, Kolski JM, Fowler JE Jr. A randomized prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 1999;54(6):1017‐21. [MEDLINE: ] - PubMed
Suvakovic 1996 {published data only}
    1. Suvakovic N, Hindmarsh JR. A step towards day case prostatectomy.. Br J Urol 1996;77:212‐4. - PubMed
Tuhkanen 1999b {published data only}
    1. Tuhkanen K, Heino A, Alaopas M. Hybrid laser treatment compared with transurethral resection of the prostate for symptomatic bladder outlet obstruction caused by a large benign prostate: a prospective, randomized trial with a 6‐month follow‐up. BJU Int 1999;84(7):805‐9. [MEDLINE: ] - PubMed
Tuhkanen 1999a {published data only}
    1. Tuhkanen K, Heino A, Ala‐Opas M. Contact laser prostatectomy compared to TURP in prostatic hyperplasia smaller than 40 ml. Six‐month follow‐up with complex urodynamic assessment. Scand J Urol Nephrol 1999;33:31‐4. - PubMed
van Melick 2002 {published data only}
    1. Melick HH, Venrooij GE, Eckhardt MD, Boon TA. A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: urodynamic effects. J Urol 2002;168(3):1058‐62. - PubMed
van Melick 2003 {published data only}
    1. Melick HH, Venrooij GE, Eckhardt MD, Boon TA. A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: analysis of subjective changes, morbidity and mortality. J Urol 2003;169(4):1411‐6. - PubMed
Zorn 1999 {published data only}
    1. Zorn BH, Bauer JJ, Ruiz HE, Thrasher JB. Randomized trial of safety and efficacy of transurethral resection of the prostate using contact laser versus electrocautery. Techniques in Urology 1999;5(4):198‐201. [MEDLINE: ] - PubMed

References to studies excluded from this review

Albert 1997 {published data only}
    1. Albert P, Bretheau D, Taverna GL, Aimino R, Morin N, Salvo A. [Laser‐assisted endoscopic resection: a new surgical technique for the treatment of benign prostatic hypertrophy. Preliminary results of a study involving 100 patients [Italian]]. Arch Ital Urol Androl 1997;69:15‐21. - PubMed
Beerlage 1998 {published data only}
    1. Beerlage HP, Francisca EA, d'Ancona FC, Debruyne FM, Rosette JJ. [Urolase v ultraline fibers in laser prostatectomy: 3‐year follow‐up of a randomized study]. J Endourol 1998;12:575‐80. - PubMed
Boon 1995 {published data only}
    1. Boon TA, Swol CF, Venrooij GE, Beerlage HP, Verdaasdonk RM. [Laser prostatectomy for patients with benign prostatic hyperplasia: a prospective randomized study comparing two different techniques using the Prolase‐II fiber]. World J Urol 1995;13(2):123‐5. [MEDLINE: ] - PubMed
Breteau 1997 {published data only}
    1. Breteau D, Koutani A, Albert P, Morin N, Salvo A. The VLAP system (Visual Laser Ablation of the Prostate): comparative study of the contact versus non‐contact techniques in a series of 100 cases [French]. Prog Urol CONFIRM 1997;7(2):235‐9. - PubMed
Bryan 1999 {published data only}
    1. Bryan NP, Byrne L, Hastie KJ, Anderson JB, Moore KT, Chapple CR. [A pilot study for a randomized controlled trial comparing the efficacy, safety and cost‐effectiveness of surgical treatments of the prostate]. BJU Int 1999;83(3):249‐53. [MEDLINE: ] - PubMed
Carter 1999b {published data only}
    1. Carter A, Sells H, Speakman M, Ewings P, O'Boyle P, MacDonagh R. [Quality of life changes following KTP/Nd:YAG laser treatment of the prostate and TURP]. Eur Urol 1999;36:92‐8. - PubMed
de la Rosette 1995 {published data only}
    1. Beerlage HP, Francisca EA, d'Ancona FC, Debruyne FM, Rosette JJ. [Urolase v ultraline fibers in laser prostatectomy: 3‐year follow‐up of a randomized study]. J Endourol 1998;12(6):575‐80. [MEDLINE: ] - PubMed
    1. Rosette JJ, Slaa E, Wildt MJ, Debruyne FM. [Experience with the Ultraline and Urolase laser fibers: is there any difference?]. World J Urol 1995;13(2):98‐103. [MEDLINE: ] - PubMed
Fraundorfer 2001 {published data only}
    1. Fraundorfer MR, Gilling PJ, Kennett KM, Dunton NG. [Holmium laser resection of the prostate is more cost effective than transurethral resection of the prostate: results of a randomized prospective study]. Urology 2001;57:454‐8. - PubMed
Gilling 1998b {published data only}
    1. Gilling PJ, Cass CB, Malcolm A, Cresswell M, Fraundorfer MR, Kabalin JN. [Holmium laser resection of the prostate versus neodymium:yttrium‐aluminum‐garnet visual laser ablation of the prostate: a randomized prospective comparison of two techniques for laser prostatectomy]. Urology 1998;51:573‐7. - PubMed
Gilling 2000 {published data only}
    1. Gilling PJ, Kennett KM, Fraundorfer MR. [Holmium laser resection v transurethral resection of the prostate: results of a randomized trial with 2 years of follow‐up]. J Endourol 2000;14:757‐60. - PubMed
Ichiyanagi 1997 {published data only}
    1. Ichiyanagi O, Ishigooka M, Hashimoto T, Hayani S, Suzuki Y, Nakada T. [The American Urological Association Symptom Index: early postoperative evaluation of irritative and obstructive symptoms due to benign prostatic hyperplasia]. Int Urol Nephrol 1997;29(4):441‐7. [MEDLINE: ] - PubMed
Jung 1996 {published data only}
    1. Jung P, Mattelaer P, Wolff JM, Mersdorf A, Jakse G. [Visual laser ablation of the prostate: efficacy evaluated by urodynamics and compared to TURP]. Eur Urol 1996;30(4):418‐23. [MEDLINE: ] - PubMed
Kaplan 1995 {published data only}
    1. Kaplan SA, Te AE. [A comparative study of transurethral resection of the prostate using a modified electro‐vaporizing loop and transurethral laser vaporization of the prostate]. J Urol 1995;154:1785‐90. - PubMed
Keoghane 1996 {published data only}
    1. Keoghane SR, Lawrence KC, Gray AM, Chappel DB, Hancock AM, Cranston DW. [The Oxford Laser Prostate Trial: economic issues surrounding contact laser prostatectomy]. Br J Urol 1996;77:386‐90. - PubMed
Keoghane 2000b {published data only}
    1. Keoghane SR, Lawrence KC, Gray AM, Doll HA, Hancock AM, Turner K, Sullivan ME, Dyar O, Cranston D. [A double‐blind randomized controlled trial and economic evaluation of transurethral resection vs contact laser vaporization for benign prostatic enlargement: a 3‐year follow‐up]. BJU Int 2000;85:74‐8. - PubMed
Kollmorgen 1996 {published data only}
    1. Kollmorgen TA, Malek RS, Barrett DM. [Laser prostatectomy: two and a half years' experience with aggressive multifocal therapy]. Urology 1996;48(2):217‐22. [MEDLINE: ] - PubMed
Langley 1997 {published data only}
    1. Langley SE, Gallegos CR, Moisey CU. [A prospective randomized trial evaluating endoscopic Nd:YAG laser prostate ablation with or without potassium titanyl phosphate (KTP) laser bladder neck incision]. Br J Urol 1997;80(6):880‐4. [MEDLINE: ] - PubMed
Matsuoka 2000 {published data only}
    1. Matsuoka K, Iida S, Tomiyasu K, Shimada A, Noda S. [Transurethral holmium laser resection of the prostate]. J Urol 2000;163:515‐8. - PubMed
McAllister 2000 {published data only}
    1. McAllister WJ, Absalom MJ, Mir K, Shivde S, Anson K, Kirby RS, Lawrence WT, Paterson PJ, Watson GM, Fowler CG. [Does endoscopic laser ablation of the prostate stand the test of time? Five‐year results from a multicentre randomized controlled trial of endoscopic laser ablation against transurethral resection of the prostate.]. BJU Int 2000;85:437‐9. - PubMed
Muschter 1995 {published data only}
    1. Muschter R, Hofstetter A. [Interstitial laser therapy outcomes in benign prostatic hyperplasia]. J Endourol 1995;9(2):129‐35. [MEDLINE: ] - PubMed
Narayan 1995 {published data only}
    1. Narayan P, Tewari A, Aboseif S, Evans C. [A randomized study comparing visual laser ablation and transurethral evaporation of prostate in the management of benign prostatic hyperplasia]. J Urol 1995;154(6):2083‐8. - PubMed
Orihuela 1995 {published data only}
    1. Orihuela E, Motamedi M, Pow‐Sang M, DeAngelis A, Cammack T, LaHaye M, Torres J, Warren MM. [Randomized clinical trial comparing low power‐slow heating versus high power‐rapid heating noncontact neodymium:yttrium‐aluminum‐garnet laser regimens for the treatment of benign prostatic hyperplasia]. Urology 1995;45(5):783‐9. - PubMed
Schatzl 1997 {published data only}
    1. Schatzl G, Madersbacher S, Djavan B, Lang T, Marberger M. [Two‐year results of transurethral resection of the prostate versus four 'less invasive' treatment options]. Eur Urol 2000;37:695‐701. - PubMed
    1. Schatzl G, Madersbacher S, Lang T, Marberger M. [The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives]. J Urol 1997;158(1):105‐10. [MEDLINE: ] - PubMed
Shingleton 2002 {published data only}
    1. Shingleton WB, Farabaugh P, May W. Three‐year follow‐up of laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 2002;60(2):305‐8. - PubMed
Tuhakanen 2001 {published data only}
    1. Tuhkanen K, Heino A, Ala‐Opas M. [Two‐year follow‐up results of a prospective randomized trial comparing hybrid laser prostatectomy with TURP in the treatment of big benign prostates]. Scand J Urol Nephrol 2001;35:200‐4. - PubMed
Wada 2000 {published data only}
    1. Wada S, Yoshimura R, Kyo M, Hase T, Masuda C, Watanabe Y, et al. [Comparative study of transurethral laser prostatectomy versus transurethral electroresection for benign prostatic hyperplasia]. Int J Urol 2000;7:373‐7. - PubMed

References to studies awaiting assessment

McCullough 1994 {published data only}
    1. McCullough DL. [Transurethral ultrasound‐guided laser induced prostatectomy (TULIP) for the treatment of BPH]. Seminars in Urology 1994;12(3):161‐4. [MEDLINE: ] - PubMed

Additional references

Albert 1997
    1. Albert P, Bretheau D, Taverna GL, Aimino R, Morin N, Salvo A. Laser‐assisted endoscopic resection: a new surgical technique for the treatment of benign prostatic hypertrophy. Preliminary results of a study involving 100 patients [Italian]. Arch Ital Urol Androl 1997;69:15‐21. - PubMed
AUA 2003
    1. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 2003;170(2 Pt 1):530‐47. - PubMed
Barry 1990
    1. Barry MJ. Medical outcomes research and benign prostatic hyperplasia. Prostate 1990;3(Suppl):61‐74. - PubMed
DerSimonian 1986
    1. DerSimonian R, Laird N. Meta‐analysis in clinical trials. Control Clin Trials 1986;7:177‐88. - PubMed
Dickersin 1994
    1. Dickersin K, Scherer R, Lefebvre C. Indentifying relevant studies for systematic reviews. BMJ 1994;312:944‐47. - PMC - PubMed
Dixon 1995
    1. Dixon CM. Lasers for treatment of benign prostatic hyperplasia. Urol Clin North Am 1995;22:413‐22. - PubMed
Jepsen 1998
    1. Jepsen JV, Bruskewitz RC. Recent developments in the surgical management of benign prostatic hyperplasia. Urology 1998;51(Suppl 4A):23‐31. - PubMed
Kaplan 1998
    1. Kaplan SA. Minimally invasive alternative therapeutic options for lower urinary tract symptoms. Urology 1998;51(Suppl 4A):32‐7. - PubMed
Lepor 1996
    1. Lepor H, Oesterling JE, Wasson JH. BPH management: minimal to maximal. Patient Care 1996:18‐35.
McConnell 1994
    1. McConnell JD, Barry MJ, Bruskewitz RC, et al. Benign prostatic hyperplasia: diagnosis and treatment. Rockville, Maryland: U.S. Department of Health and Human Services. Public Health Service. Agency for Health Care Policy and Research, 1994. - PubMed
Oesterling 1995
    1. Oesterling JE. Benign prostatic hyperplasia. Medical and minimally invasive treatment options. New Engl J Med 1995;332:99‐109. - PubMed
Roos 1998
    1. Roos NP, Wennberg JE, Malenka DJ, et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 1998;320:1120‐4. - PubMed
Schulz 1995
    1. Schulz KF, Chalmers I, Hayes RJ Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408‐12. - PubMed
Tewari 1999
    1. Tewari A, Oleska J, Johnson C, et al. Minimally invasive therapy of benign prostatic hypertrophy. Hospital Physician 1999;68:29‐43.
Wasson 1995
    1. Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG. Comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med 1995;332:75‐9. - PubMed

References to other published versions of this review

Hoffman 2003
    1. Hoffman RM, MacDonald R, Slaton JW, Wilt TJ. [Laser prostatectomy versus transurethral resection for treating benign prostatic obstruction: a systematic review]. J Urol 2003;169:210‐15. - PubMed

Publication types